CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Grant or award Chief Financial Officer acquired 15,001 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 26,668 shares (grant or award)
- 4 Grant or award Pres., R&D, and CMO acquired 20,001 shares (grant or award)
- 8-K Event Other events
- 4 Open-market sale SVP and General Counsel sold 13,000 shares at an average $282.92 ($3,677,977)
- 4 Open-market sale SVP and General Counsel sold 7,000 shares at an average $274.18 ($1,919,231)
- 4 Open-market sale Chief Commercial Officer sold 30,000 shares at an average $274.14 ($8,224,073)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Bylaws or fiscal year change · Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 20 of 62 · 1,224 filings